An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of Three Orally Disintegrating Tablet Formulations Of Sildenafil Without Water Relative To Viagra(TM) Conventional Oral Tablet With Water.

Trial Profile

An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of Three Orally Disintegrating Tablet Formulations Of Sildenafil Without Water Relative To Viagra(TM) Conventional Oral Tablet With Water.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Cardiovascular disorders; Erectile dysfunction; Female infertility; Pulmonary hypertension
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 07 Oct 2009 Actual initiation date (Aug 2009) added as reported by ClinicalTrials.gov.
    • 07 Oct 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Sep 2009 Planned initiation date changed from 1 Aug 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top